Literature DB >> 8442099

Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.

E Holler1, H J Kolb, R Hintermeier-Knabe, J Mittermüller, S Thierfelder, M Kaul, W Wilmanns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8442099

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  20 in total

1.  Hematopoietic stem cell transplantation: current status of old issues.

Authors:  N Kapoor
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

2.  [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD].

Authors:  R Travnik; M Beckers; D Wolff; E Holler; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

3.  [Cutaneous graft-versus-host disease].

Authors:  S Karrer
Journal:  Hautarzt       Date:  2003-05       Impact factor: 0.751

4.  Murine graft-versus-host disease induced using interferon-gamma-deficient grafts features antibodies to double-stranded DNA, T helper 2-type cytokines and hypereosinophilia.

Authors:  Cynthia A Ellison; David S Bradley; Jacqie M M Fischer; Kent T Hayglass; John G Gartner
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

5.  Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplants.

Authors:  Archana Thakur; Carly Sorenson; Oxana Norkina; Dana Schalk; Voravit Ratanatharathorn; Lawrence G Lum
Journal:  Transfusion       Date:  2011-07-11       Impact factor: 3.157

Review 6.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.

Authors:  Mehdi Hamadani; Craig C Hofmeister; Buffy Jansak; Gary Phillips; Patrick Elder; William Blum; Sam Penza; Thomas S Lin; Rebecca Klisovic; Guido Marcucci; Sherif S Farag; Steven M Devine
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

8.  Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.

Authors:  Carrie L Kitko; Sophie Paczesny; Gregory Yanik; Thomas Braun; Dawn Jones; Joel Whitfield; Sung W Choi; Raymond J Hutchinson; James L M Ferrara; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

Review 9.  The pathophysiology of acute graft-versus-host disease.

Authors:  James L M Ferrara; Kenneth R Cooke; Takanori Teshima
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

10.  Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

Authors:  Sung W Choi; Carrie L Kitko; Thomas Braun; Sophie Paczesny; Gregory Yanik; Shin Mineishi; Oleg Krijanovski; Dawn Jones; Joel Whitfield; Kenneth Cooke; Raymond J Hutchinson; James L M Ferrara; John E Levine
Journal:  Blood       Date:  2008-05-23       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.